cancer clinical trials in nashville, TN
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee 37064 Breast Cancer
|
Tennessee Oncology
Nashville, Tennessee 37203 Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Solid Tumors, Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Breast Cancer
|
Nashville, Tennessee 37203-1632 Glioblastoma
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Lymphoma
|
Vanderbilt-Ingram Cancer Center
Trial Locations Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center - Cool Springs Cancer
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
|
Nashville, Tennessee 37203-1632 Myelofibrosis
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Peripheral Nerve Injury, Prostate Cancer, Radical Prostatectomy, Nerve Reconstruction, Cavernous Nerve Injury
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Arthralgia, Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Head and Neck Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Leukemia
|
Vanderbilt-Ingram Cancer Center
Trial Locations Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center - Cool Springs Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm
|
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Nashville, Tennessee 37232 Leukemia, Lymphoma
|
Nashville, Tennessee 37203-1632 Non-small Cell Lung Cancer
|
Nashville, Tennessee 37203-1632 Castration-Resistant Prostate Cancer
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Brain and Central Nervous System Tumors, Neurotoxicity
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
|
Vanderbilt Children's Hospital
Nashville, Tennessee 37232-6310 Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer, Stage III Gastric Cancer, Stage IV Gastric Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Pancreatic Cancer, Periampullary Adenocarcinoma
|
Nashville, Tennessee 37203-1632 Thyroid Neoplasms
|
Vanderbilt-Ingram Cancer Center
Trial Locations Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center - Cool Springs Lung Cancer
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Prostate Cancer
|
The Vanderbuilt Clinic
Trial Locations The Vanderbuilt Clinic Clinical Trials Center Acute Myeloid Leukemia
|
Nashville, Tennessee 37203-1632 Solid Cancers
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Lymphoma, Lymphoproliferative Disorder
|
Nashville, Tennessee 37203-1632 Malignant Melanoma
|
Sarah Cannon Research Institute SC
Nashville, Tennessee 37203 Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication,, Advanced Solid Tumors With FGFR3 Mutation
|
Vanderbilt-Ingram Medical Center
Nashville, Tennessee 37232 At This Time, All Cohorts Are Closed to Enrollment With the Exception of the Pigmented Villo-nodular Synovitis (PVNS) Cohort.
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Severe Thalassemia
|
Nashville, Tennessee 37203-1632 Malignant Melanoma
|
Vanderbilt
Nashville, Tennessee 37212 Refractory Cutaneous T-cell Lymphoma
|
Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(6)
Nashville, Tennessee 37203 HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Endometrial Papillary Serous Carcinoma, Localized Unresectable Adult Primary Liver Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Carcinosarcoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Papillary Serous Carcinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Pulmonary Carcinoid Tumor, Recurrent Adult Primary Liver Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Regional Gastrointestinal Carcinoid Tumor, Stage IIIA Endometrial Carcinoma, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Endometrial Carcinoma, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Endometrial Carcinoma, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer, Stage IVA Endometrial Carcinoma, Stage IVB Endometrial Carcinoma, Uterine Carcinosarcoma
|
Sarah Cannon Research Institute (SCRI)
Nashville, Tennessee 37203 Advanced Solid Tumors
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
|
Meharry Medical College
Trial Locations Meharry Medical College Nashville Oncology Associates PC Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
|
Vanderbilt Univeristy SC
Nashville, Tennessee 37232 Multiple Myeloma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
|
Vanderbilt University Medical Center SC Vanderbilt
Nashville, Tennessee 37232 Melanoma
|
Vanderbilt Therapeutics CRS (3652)
Nashville, Tennessee 37232 HIV Infections
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Non Small Cell Lung Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer, Liver Neoplasms
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Leukemia
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
|
Tennessee Oncology
Nashville, Tennessee 37203 Multiple Myeloma
|
Nashville, Tennessee 37203-1632 Advanced Solid Malignancies
|
Nashville, Tennessee 37203-1632 Metastatic Colorectal Cancer
|
Nashville, Tennessee 37203-1632 Solid Cancers
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Cancer Survivor, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Testicular Germ Cell Tumor
|
SCRI
Nashville, Tennessee 37203 Chronic Lymphocytic Leukemia
|
Investigational Site Number 840101
Nashville, Tennessee 37203 Squamous Cell Lung Cancer
|
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC
Nashville, Tennessee 37212 Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
|